Neurometabolic Disorders 2
The Neurometabolic Disorders 2 session will be discussing creatine synthesis/transport, Purine/pyrimidine metabolism.
This educational activity is supported by an educational grant from Ultragenyx.
- List phenotypes and identify biochemical findings of disorders of neurotransmitter biosynthesis and recycling.
- Describe approaches to therapy for neurotransmitter disorders.
- Detail the roles of serine in neurons, consequences of serine deficiency and potential therapies.
- Identify signs, symptoms and laboratory abnormalities for disorders of riboflavin, pyridoxine and folate biosynthesis and transport.
Reid Sutton, MD
Reid Sutton, MD, speaker for this session, is a site principle investigator for Ultragenyx and an advisory board member for Applied Therapeutics, Horizon and Aceragen Therapeutics, is a consultant for Chiesi Pharma and a speaker for Abbott Nutrition.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance